At the Crossroads of Clinical and Preclinical Research for Muscular Dystrophy-Are We Closer to Effective Treatment for Patients?

Main|Search|PHGKB






Last Posted: May 25, 2018

---

• 2018 D&I - Call for Abstracts  
  Academy Health, May 2018- Accepting abstracts till July 24
• At the Crossroads of Clinical and Preclinical Research for Muscular Dystrophy-Are We Closer to Effective Treatment for Patients?  
  Gawlik Kinga I et al. International journal of molecular sciences 2018 May 19(5)
• Creation and Implementation of an Environmental Scan to Assess Cancer Genetics Services at Three Oncology Care Settings.  
  Bednar Erica M et al. Journal of genetic counseling 2018 May
• Human plasma and serum extracellular small RNA reference profiles and their clinical utility.  
  Max Klaas E A et al. Proceedings of the National Academy of Sciences of the United States of America 2018 May
• Inequities in genetic testing for hereditary breast cancer: implications for public health practice.  
  Sayani Ambreen et al. Journal of community genetics 2018 May
• Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?  
  Stillemans Gabriel et al. Expert opinion on drug metabolism & toxicology 2018 May
• Precision Medicine in Hormone Receptor-Positive Breast Cancer.  
  Nasrazadani Azadeh et al. Frontiers in oncology 2018 8144
• Strategies to Guide the Return of Genomic Research Findings: An Australian Perspective.  
  Eckstein Lisa et al. Journal of bioethical inquiry 2018 May
• Understanding barriers to the introduction of precision medicines in non-small cell lung cancer: A qualitative interview protocol.  
  Wright Stuart et al. Wellcome open research 2018 324
• Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.  
  Wellmann Rebecca et al. Cancer 2018 May

more